Icadmed
Nashua, US · 1 known investors
Find your way into Icadmed
Sign up to see every warm intro you have to Icadmed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Icadmed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
iCAD develops FDA-cleared, AI-based solutions for breast cancer detection, breast density assessment, and risk evaluation, used by radiologists in mammography workflows. Its offerings support 2D and 3D digital breast tomosynthesis screening to aid earlier cancer detection.
Investors · 1
New Science Ventureslisted by New Science VenturesGreenwich · $2M – $8M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Icadmed do?
- iCAD develops FDA-cleared, AI-based solutions for breast cancer detection, breast density assessment, and risk evaluation, used by radiologists in mammography workflows. Its offerings support 2D and 3D digital breast tomosynthesis screening to aid earlier cancer detection.
- Who are Icadmed's investors?
- Icadmed's investors include New Science Ventures.
- Where is Icadmed headquartered?
- Icadmed is headquartered in Nashua, US.
